We develop, protect, and license breakthrough microbial and nanotechnology IP. Strategic partnerships for enterprises seeking exclusive technology advantage.
Long before humans walked the Earth, single-celled organisms were terraforming the planet, creating the conditions for all complex life.
Microorganisms appear on Earth. Cyanobacteria begin oxygenic photosynthesis, slowly transforming the planet's atmosphere from anoxic to oxygen-rich.
Microbial metabolites flood the atmosphere with oxygen. The Great Oxidation Event triggers mass extinction of anaerobic life but enables aerobic respiration — and ultimately, multicellular life.
Mitochondria and chloroplasts evolve from engulfed bacteria. Every cell in your body carries descendants of ancient microbes — you are, in essence, a microbial consortium.
We now know that microbes control human health, regulate climate, drive nutrient cycles, and hold the keys to biotech innovation. We are entering a new era of microbial engineering.
At AISCKOP, we believe the next leap in evolution is not biological chance — it is intelligent design guided by microbial science. We are building the tools to accelerate this transition, helping industries harness 3.8 billion years of evolutionary R&D to solve modern challenges.
One nanometer is to a meter what a marble is to the Earth. At this scale, the rules of classical physics give way to quantum mechanics — and entirely new material properties emerge.
From targeted drug delivery to self-healing materials, nanotechnology is transforming every industry it touches. The global market is projected to reach $290 billion by 2032.
Explore NanotechnologyWe develop and protect proprietary microbial and nanotechnology IP. License exclusive rights, co-develop, or acquire full technology transfer.
All engagements are bespoke. Terms available under NDA.
Browse our technology portfolio of engineered strains, nanoparticles, and biomaterials. All technologies are validated, protected, and available for strategic licensing.